Adaptimmune Limited

ADAPTIMMUNE

Pharmaceutical preparations for the treatment of cancer and autoimmune diseases;Medical treatment services, namely, administration of gene therapy to patients involving harvesting a patient's white blood cells, transducing or combining white blood cells with gene encoding T-cell receptor and re-administration of white blood cells to patient; Medical and therapeutic services, namely immunotherapy services comprising harvesting a patient's white blood cells, transducing the white blood cells with the gene encoding the engineered T-cell receptor and re-administration of the transduced white blood cells back into the patient;

ADAPTIMMUNE

The mark consists of a stylized circular design consisting of several curved parallel lines to the left of the stylized wording ADAPTIMMUNE.;Pharmaceutical preparations for the treatment of cancer and autoimmune diseases; pharmaceutical immunotherapy preparations for use in cancer treatment; T-cell receptors , namely, pharmaceutical preparations for use in cancer treatment; pharmaceutical immunotherapy preparations comprising engineered T-cell receptors for use in cancer treatment; pharmaceutical immunotherapy preparations comprising genes encoding engineered T-cell receptors for use in cancer treatment;ADAPT IMMUNE;Medical treatment services; medical immunotherapy services; medical treatment services and medical treatment services for immune-therapy comprising harvesting a patient's white blood cells, combining white blood cells with an engineered T-cell receptor therapeutic, transducing the white blood cells with the gene encoding the engineered T-cell receptor and infusion of the transduced white blood cells back into the patient;